掃碼下載
BTC $62,907.76 +2.14%
ETH $1,666.87 +4.73%
BNB $600.92 +3.52%
XRP $1.13 +2.90%
SOL $65.95 +3.76%
TRX $0.3268 +0.99%
DOGE $0.0854 +2.46%
ADA $0.1631 +1.16%
BCH $221.17 -0.05%
LINK $7.83 +3.47%
HYPE $61.13 +5.97%
AAVE $62.71 +0.91%
SUI $0.7467 -0.43%
XLM $0.2003 -4.89%
ZEC $430.40 +13.55%
BTC $62,907.76 +2.14%
ETH $1,666.87 +4.73%
BNB $600.92 +3.52%
XRP $1.13 +2.90%
SOL $65.95 +3.76%
TRX $0.3268 +0.99%
DOGE $0.0854 +2.46%
ADA $0.1631 +1.16%
BCH $221.17 -0.05%
LINK $7.83 +3.47%
HYPE $61.13 +5.97%
AAVE $62.71 +0.91%
SUI $0.7467 -0.43%
XLM $0.2003 -4.89%
ZEC $430.40 +13.55%

彭博社:Arthur Hayes 近期重金投資某人類壽命延長公司,過去 1 年定期接受幹細胞靜脈輸注治療

2025-08-21 09:43:07
收藏

ChainCatcher 消息,据彭博社報導,BitMEX 聯合創始人 Arthur Hayes 正將投資目光轉向人類壽命延長領域,其近期重金投資了一家在墨西哥和曼谷設有診所的幹細胞企業,並加入其董事會。

過去一年他定期乘機前往接受靜脈輸注治療,直言"希望儘可能健康地延長壽命"。儘管因品牌重塑暫未透露公司名稱,但他強調:這是未來趨勢------越來越多國家正放寬幹細胞使用法規。

app_icon
ChainCatcher 與創新者共建Web3世界